Chronic Rhinosinusitis clinical trials at UC Irvine

1 research study open to eligible people

LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)
open to eligible people ages 18 years and up
Multicenter, phase III, randomized, blinded, controlled, parallel group.
Orange, California and other locations

Last updated: September 23, 2024